• Return to Headlines

Endologix Inc Shares Up 7.7% Since SmarTrend's Buy Recommendation (ELGX)

By David Diaz

SmarTrend identified an Uptrend for Endologix Inc (NASDAQ:ELGX) on March 6th, 2019 at $6.20. In approximately 2 months, Endologix Inc has returned 7.74% as of today's recent price of $6.68.

Over the past year, Endologix Inc has traded in a range of $0.05 to $7.49 and is now at $6.68, 13,260% above that low. Over the past week, the 200-day moving average (MA) has gone up 5.6% while the 50-day MA has advanced 6.5%.

Endologix, Inc. develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. The Company's products include the Powerlink System, a catheter-based endoluminal stent graft that treats abdominal aortic aneurysms. Endologix's products are sold in the United States, as well as international markets.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Endologix Inc shares.

Log in and add Endologix Inc (ELGX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights endologix inc

Ticker(s): ELGX